Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis

INTRODUCTION: This study evaluated the efficacy of the interleukin-17A inhibitor secukinumab in patients with oligoarticular psoriatic arthritis (PsA). METHODS: A total of 84 patients with oligoarticular PsA, defined as 1–4 tender joints and 1–4 swollen joints, were pooled from the FUTURE 2–5 and MA...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogdie, Alexis, Gladman, Dafna D., Coates, Laura C., Pournara, Effie, Parikh, Bhumik, Mease, Philip J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326182/
https://www.ncbi.nlm.nih.gov/pubmed/37148474
http://dx.doi.org/10.1007/s40744-023-00548-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326182/
https://www.ncbi.nlm.nih.gov/pubmed/37148474
http://dx.doi.org/10.1007/s40744-023-00548-y

Ejemplares similares